Semax
Semax (Synthetic ACTH 4-10 Analogue)
Research Use Only
All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.
Semax Overview
Semax is a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH 4-10) with the addition of a C-terminal Pro-Gly-Pro sequence. It is studied in laboratory and preclinical models for its influence on neuronal signaling, CNS pathway dynamics, and molecular stress responses. Research has investigated its ability to modulate neurotrophic factor expression, neurotransmitter systems, and oxidative stress pathways.
History
Semax was developed in Russia in the 1980sā1990s as part of research on synthetic peptides with potential neuromodulatory effects. It was designed to retain the neuroactive core of ACTH while eliminating hormonal activity, thereby providing a stable and non-hormonal peptide for CNS research. Over time, studies expanded into its roles in neuronal signaling characterization, synaptic plasticity, and regulation of gene expression in experimental brain models.
Research Findings
Semax has been studied in neurological, CNS, and systemic models, with research highlighting its role in neuronal signaling, synaptic pathway dynamics, and stress response. Studies also report activity in neurotransmitter modulation, oxidative stress pathways, and signaling dynamics in preclinical settings.
Key Areas of Research:
-
Neurological: Neuronal signaling, pathways, cascades
-
CNS: Synaptic plasticity, signaling, function
-
Systemic: Stress pathways, remodeling, resilience
Together, these findings suggest broad experimental potential for Semax across neurological, CNS, and systemic pathways. By influencing neurotransmitter systems and supporting signaling and pathway responses, Semax provides a versatile platform for research into CNS dynamics, stress biology, and systemic resilience in laboratory settings.